WallStreetZenWallStreetZen

NASDAQ: TRIB
Trinity Biotech PLC Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their TRIB stock forecasts and price targets.

Forecast return on equity

Is TRIB forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is TRIB forecast to generate an efficient return on assets?

TRIB revenue forecast

What is TRIB's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$67.0M+17.89%
Avg 2 year Forecast
$73.5M+29.33%
TRIB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TRIB revenue growth forecast

How is TRIB forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
17.89%
Industry
3.73%
Market
12.87%
TRIB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TRIB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TRIB vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
TRIB$1.83N/AN/A
STRR$0.88N/AN/A
PMD$2.54N/AN/A
CHEK$2.27N/AN/A
CNTG$0.48N/AN/A

Trinity Biotech Stock Forecast FAQ

What is TRIB's revenue growth forecast for 2024-2025?

(NASDAQ: TRIB) Trinity Biotech's forecast annual revenue growth rate of 17.89% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.73%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.87%.

Trinity Biotech's revenue in 2024 is $56,832,000.On average, 1 Wall Street analysts forecast TRIB's revenue for 2024 to be $10,271,788,760, with the lowest TRIB revenue forecast at $10,271,788,760, and the highest TRIB revenue forecast at $10,271,788,760.

In 2025, TRIB is forecast to generate $11,268,305,580 in revenue, with the lowest revenue forecast at $11,268,305,580 and the highest revenue forecast at $11,268,305,580.

If you're new to stock investing, here's how to buy Trinity Biotech stock.

What is TRIB's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: TRIB) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 3.09%.

What is TRIB's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: TRIB) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.